NASDAQ : LMAT
LeMaitre Vascular, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 80.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.85B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.85B |
| Enterprise Value | 1.67B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Aug 20, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 22.87M |
| Shares Outstanding | 22.87M |
| Shares Change (YoY) | +3.65% |
| Shares Change (QoQ) | +6.51% |
| Owned by Insiders (%) | 6.84% |
| Owned by Institutions (%) | 102.95% |
| Float | 21.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 28.33 |
| Forward PE | 26.48 |
| PS Ratio | 7.05 |
| Forward PS | 6.38 |
| PB Ratio | 4.40 |
| P/TBV Ratio | 5.72 |
| P/FCF Ratio | 25.07 |
| P/OCF Ratio | 22.31 |
| PEG Ratio | 1.66 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.35 |
| EV / Sales | 6.34 |
| EV / EBITDA | 20.06 |
| EV / EBIT | 22.96 |
| EV / FCF | 22.55 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 16.31 |
| Quick Ratio | 13.76 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 2.15 |
| Debt / FCF | 2.58 |
| Interest Coverage | 13.95 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 16.77% |
| Return on Assets (ROA) | 7.44% |
| Return on Invested Capital (ROIC) | 24.25% |
| Return on Capital Employed (ROCE) | 11.88% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | $400,660 |
| Profits Per Employee | $100,264 |
| Employee Count | 655 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.06 |
Taxes
| Measure | Value |
|---|
| Income Tax | 19.06M |
| Effective Tax Rate | 22.50% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -8.92% |
| 50-Day Moving Average | 81.20 |
| 200-Day Moving Average | 94.47 |
| Relative Strength Index (RSI) | 45.37 |
| Average Volume (20 Days) | 269,190 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.78M |
| Short Previous Month | 1.74M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 8.34% |
| Short Ratio (days to cover) | 6.66 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 262.43M |
| Gross Profit | 188.61M |
| Operating Income | 72.52M |
| Pretax Income | 84.73M |
| Net Income | 65.67M |
| EBITDA | 83.02M |
| EBIT | 72.52M |
| Earnings Per Share (EPS) | $2.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 376.24M |
| Total Debt | 190.25M |
| Net Cash | 185.99M |
| Net Cash Per Share | $8.13 |
| Equity (Book Value) | 420.34M |
| Book Value Per Share | 18.38 |
| Working Capital | 458.36M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 82.98M |
| Capital Expenditures | -9.15M |
| Depreciation & Amortization | 10.50M |
| Net Borrowing | n/a |
| Free Cash Flow | 73.83M |
| FCF Per Share | $3.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.87% |
| Operating Margin | 27.63% |
| Pretax Margin | 32.29% |
| Profit Margin | 25.02% |
| EBITDA Margin | 31.64% |
| EBIT Margin | 27.63% |
| FCF Margin | 28.13% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.00 |
| Dividend Yield | 1.24% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 33.25% |
| FCF Payout Ratio | 29.43% |
| Buyback Yield | -3.65% |
| Shareholder Yield | -2.41% |
| Earnings Yield | 3.53% |
| FCF Yield | 3.99% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $107.00 |
| Price Target Difference | 32.20% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 9.48% |
| EPS Growth Forecast (3Y) | 11.17% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7.86 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |